Bank Of Montreal Kodiak Sciences Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$4.3 - $9.48 $198,488 - $437,596	46,160 Added 28.6%	207,546 $1.43 Million
Q3 2022 Nov 10, 2022	SELL	$7.57 - $12.5 $277,871 - $458,837	-36,707 Reduced 18.53%	161,386 $1.85 Million
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.48 $888,773 - $1.67 Million	176,344 Added 810.81%	198,093 $1.71 Million
Q1 2022 May 12, 2022	BUY	$7.09 - $89.45 $154,200 - $1.95 Million	21,749 New	21,749 $169,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.